BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37589180)

  • 1. Laser induced fluorescence spectroscopy analysis of kidney tissues: A pilot study for the identification of renal cell carcinoma.
    Pavithran M S; Lukose J; Barik BK; Periasami A; Kartha VB; Chawla A; Chidangil S
    J Biophotonics; 2023 Nov; 16(11):e202300021. PubMed ID: 37589180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Mass Spectrometry Is an Accurate Tool in Differentiating Clear Cell Renal Cell Carcinoma and Chromophobe Renal Cell Carcinoma: A Proof-of-concept Study.
    Lu HC; Patterson NH; Judd AM; Reyzer ML; Sehn JK
    J Histochem Cytochem; 2020 Jun; 68(6):403-411. PubMed ID: 32466698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
    Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
    Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
    Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
    Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of collagen and nicotinamide adenine dinucleotide in human cancerous and normal prostate tissues studied using native fluorescence spectroscopy with selective excitation wavelength.
    Pu Y; Wang W; Tang G; Alfano RR
    J Biomed Opt; 2010; 15(4):047008. PubMed ID: 20799839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size.
    Steffens S; Roos FC; Janssen M; Becker F; Steinestel J; Abbas M; Steinestel K; Wegener G; Siemer S; Thüroff JW; Hofmann R; Stöckle M; Schrader M; Hartmann A; Junker K; Kuczyk MA; Schrader AJ;
    Virchows Arch; 2014 Oct; 465(4):439-44. PubMed ID: 25178561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types.
    Wang X; Kong W; Wang Y; Wang Y; Chen Y; Shi Z; Liu Y
    J BUON; 2021; 26(5):2053-2058. PubMed ID: 34761616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fluorescence spectral characteristics of human blood and its endogenous fluorophores].
    Li BH; Zhang ZX; Xie SS; Chen R
    Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Jul; 26(7):1310-3. PubMed ID: 17020047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of specific contrast-enhanced CT regions of interest to differentiate renal oncocytomas from small clear cell and chromophobe renal cell carcinomas.
    Qu JY; Jiang H; Wang XF; Song XH; Hao CJ
    Diagn Interv Radiol; 2022 Nov; 28(6):555-562. PubMed ID: 36550755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma.
    Priolo C; Khabibullin D; Reznik E; Filippakis H; Ogórek B; Kavanagh TR; Nijmeh J; Herbert ZT; Asara JM; Kwiatkowski DJ; Wu CL; Henske EP
    Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6274-E6282. PubMed ID: 29891694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and survival analysis of clinically advanced papillary and chromophobe renal cell carcinoma.
    Kaldany A; Paulucci DJ; Kannappan M; Beksac AT; Anastos H; Okhawere K; Sfakianos JP; Badani KK
    Urol Oncol; 2019 Oct; 37(10):727-734. PubMed ID: 31174958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between autofluorescence intensity and tumor area in mice bearing renal cell carcinoma.
    Bellini MH; Coutinho EL; Courrol LC; Rodrigues de Oliveira Silva F; Vieira Júnior ND; Schor N
    J Fluoresc; 2008 Nov; 18(6):1163-8. PubMed ID: 18488145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical spectroscopy characteristics can differentiate benign and malignant renal tissues: a potentially useful modality.
    Parekh DJ; Lin WC; Herrell SD
    J Urol; 2005 Nov; 174(5):1754-8. PubMed ID: 16217277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leptin and its receptor: can they help to differentiate chromophobe renal cell carcinoma from renal oncocytoma?
    Ng KL; Del Vecchio SJ; Samaratunga H; Morais C; Rajandram R; Vesey DA; Wood ST; Gobe GC
    Pathology; 2018 Aug; 50(5):504-510. PubMed ID: 29970253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
    Halefoglu AM; Ozagari AA
    Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series.
    Casuscelli J; Becerra MF; Seier K; Manley BJ; Benfante N; Redzematovic A; Stief CG; Hsieh JJ; Tickoo SK; Reuter VE; Coleman JA; Russo P; Ostrovnaya I; Hakimi AA
    Clin Genitourin Cancer; 2019 Oct; 17(5):373-379.e4. PubMed ID: 31326335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stokes shift spectroscopy pilot study for cancerous and normal prostate tissues.
    Ebenezar J; Pu Y; Wang WB; Liu CH; Alfano RR
    Appl Opt; 2012 Jun; 51(16):3642-9. PubMed ID: 22695604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of chromophobe renal cell carcinoma and papillary renal cell carcinoma with dual-energy spectral computed tomography.
    Wang D; Huang X; Bai L; Zhang X; Wei J; Zhou J
    Acta Radiol; 2020 Nov; 61(11):1562-1569. PubMed ID: 32088966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.